文献速递消化道肿瘤与早癌消化内镜

碘染色内镜筛查长期特发性贲门失弛缓症患者的异型增生

Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia.
PubMed 文献 · Am J Gastroenterol · 2018-01-01

该队列研究纳入230例贲门失弛缓症患者,自2000年1月至2016年3月每三年行碘染色内镜筛查。3例发生食管鳞状细胞癌,4例检出低级别异型增生,碘染色使可疑病灶检出数增至白光的三倍,但仅8%经组织病理学证实为癌或低级别异型增生。作者结论认为白光联合碘染色内镜不能准确识别癌前病变,因此不能系统推荐。

要点

  • 长期(>20年)贲门失弛缓症患者发生食管异型增生和癌的风险增加。
  • 碘染色使可疑病灶检出数从白光111处增至329处,仅8%经组织病理学证实。
  • 白光联合碘染色内镜不能准确识别食管鳞状细胞癌前病变,不能系统推荐。

核心结论

  • 长期(>20年)贲门失弛缓症患者发生食管异型增生和癌的风险增加。
  • 白光联合碘染色内镜不能准确识别食管鳞状细胞癌前病变,因此不能系统推荐。

研究设计与样本

  • 队列研究,纳入230例贲门失弛缓症患者(144例男性,首次内镜时中位年龄52岁,IQR 43-63),2000年1月至2016年3月每三年行碘染色内镜筛查。
  • 低级别异型增生患者每年筛查,高级别异型增生或癌患者接受治疗。

主要发现

  • 3例(1.3%,2例男性,年龄68岁,范围50-87)发生食管鳞状细胞癌,前次筛查无低级别异型增生。
  • 食管鳞状细胞癌发病率为每10万人年63(95% CI 13-183)。
  • 4例(1.7%,2例男性,年龄64岁,范围57-73)检出低级别异型增生,随访9年(IQR 7-14)期间无进展为高级别异型增生或食管鳞状细胞癌。
  • 食管鳞状细胞癌或低级别异型增生在症状出现后30年(IQR 14-36)、诊断后22年(IQR 4-13)被诊断。
  • 碘染色使可疑病灶检出数增至白光的三倍(白光111处 vs 碘染色329处),但仅8%经组织病理学证实为食管鳞状细胞癌或低级别异型增生。

临床怎么用

  • 作者结论认为白光联合碘染色内镜不能准确识别食管鳞状细胞癌前病变,因此不能系统推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Achalasia patients with longstanding disease are considered to be at risk for developing esophageal cancer. Endoscopic screening is not standardized and detection of dysplastic lesions is difficult, for which Lugol chromoendoscopy could be helpful. Aim was to evaluate the efficacy of screening for esophageal dysplasia and carcinoma in patients with longstanding achalasia using Lugol chromoendoscopy. METHODS: In this cohort study achalasia patients underwent three-annual screening by Lugol chromoendoscopy between January 2000 and March 2016. Patients with low-grade dysplasia (LGD) underwent yearly screening, patients with high-grade dysplasia (HGD) or carcinoma were treated. RESULTS: In total, 230 achalasia patients (144 male, median age 52 years (IQR 43-63) at first endoscopy) were included. Three patients (1.3%, 2 male, age 68 years (range 50-87)) developed esophageal squamous cell carcinoma (ESCC), without LGD at the preceding screening. Incidence rate for ESCC was 63 (95% CI 13-183) per 100 000 persons-years. LGD was observed in 4 patients (1.7%, 2 male, age 64 years (range 57-73)), without progression to HGD/ESCC during a follow-up of 9 (IQR 7-14) years. ESCC/LGD was diagnosed 30 (IQR 14-36) years after onset of symptoms and 22 (IQR 4-13) years after diagnosis. Lugol chromoendoscopy tripled the detection rate of suspected lesions (111 lesions white light versus 329 lesions Lugol), but only 8% was histopathological confirmed ESCC or LGD. CONCLUSION: Achalasia patients with longstanding disease (>20 years) have an increased risk to develop esophageal dysplasia and carcinoma. Endoscopic screening using white light and Lugol chromoendoscopy does not accurately identify precursor lesions for ESCC and therefore cannot be systematically recommended.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Ponds FA, Moonen A, Smout AJPM, et al. Screening for dysplasia with Lugol chromoendoscopy in longstanding idiopathic achalasia. Am J Gastroenterol. 2018. PMID: 29748564. doi:10.1038/s41395-018-0064-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。